Akebia Therapeutics
(AKBA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 87,212 | 62,741 | 104,644 | 162,430 | 163,526 |
| Marketable Securities | 49,553 | 105,297 | N/A | 227,714 | 238,597 |
| Receivables | 28,888 | 48,435 | 233,662 | 688 | 132 |
| Inventories | 122,137 | 115,206 | 114,245 | N/A | N/A |
| TOTAL | $316,396 | $347,233 | $468,275 | $397,526 | $407,417 |
| Non-Current Assets | |||||
| PPE Net | 10,903 | 9,512 | 8,023 | 3,808 | 3,726 |
| Intangibles | 364,466 | 373,566 | 383,206 | 0 | 0 |
| Other Non-Current Assets | 131,763 | 160,482 | 137,036 | 2,492 | 2,638 |
| TOTAL | $507,132 | $543,560 | $528,265 | $6,300 | $6,364 |
| Total Assets | $823,528 | $890,793 | $996,540 | $403,826 | $413,781 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 15,000 | N/A | N/A |
| Accounts payable and accrued liabilities | 19,321 | 15,226 | 42,796 | 12,684 | 4,795 |
| Accrued Expenses | 125,981 | 137,803 | 150,917 | 94,616 | 81,012 |
| TOTAL | $185,618 | $202,613 | $265,693 | $177,399 | $164,420 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 40,316 | 49,584 | 56,980 | 70,099 | 78,613 |
| Other Non-Current Liabilities | 59,967 | 61,040 | 29,573 | 41 | 69 |
| TOTAL | $118,554 | $121,801 | $94,919 | $83,886 | $83,437 |
| Total Liabilities | $304,172 | $324,414 | $360,612 | $261,285 | $247,857 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 118,864 | 117,863 | 117,122 | 57,059 | 57,045 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -644,986 | -586,816 | -514,395 | -454,341 | -428,294 |
| Other shareholders' equity | 23 | -36 | -261 | -409 | -459 |
| TOTAL | $519,356 | $566,379 | $635,928 | $142,541 | $165,924 |
| Total Liabilities And Equity | $823,528 | $890,793 | $996,540 | $403,826 | $413,781 |